Sat, Aug 16, 2025
Volume 20, Issue 2 (Summer & Autumn 2023)
ASJ 2023, 20(2): 45-54 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khaledi S, Najafpour Pitka M, Hoseini Z S, Ghorbanlou M, Shirazi R. Study the Effects of N-acetyl Cysteine and Melatonin on the Quality of Oocyte and Embryo in Women With Polycystic Ovary Syndrome. ASJ 2023; 20 (2) :45-54
URL: http://anatomyjournal.ir/article-1-224-en.html
URL: http://anatomyjournal.ir/article-1-224-en.html
Sajed Khaledi1 
, Maryam Najafpour Pitka2 , Zahra Sadat Hoseini3 , Mehrdad Ghorbanlou4 , Reza Shirazi5
, Maryam Najafpour Pitka2 , Zahra Sadat Hoseini3 , Mehrdad Ghorbanlou4 , Reza Shirazi5
1- Department of Anatomy, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
2- Department of Genetics, Faculty of Life Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran.
3- Department of Biology, Faculty of Genetics, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran.
4- Department of Anatomical Sciences, School of Medicine, Iran University of Medical Science, Tehran, Iran.
5- Department of Anatomy, School of Medical Sciences, Biomedical & Health, UNSW Sydney, Sydney, Australia.
2- Department of Genetics, Faculty of Life Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran.
3- Department of Biology, Faculty of Genetics, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran.
4- Department of Anatomical Sciences, School of Medicine, Iran University of Medical Science, Tehran, Iran.
5- Department of Anatomy, School of Medical Sciences, Biomedical & Health, UNSW Sydney, Sydney, Australia.
Abstract: (859 Views)
Introduction: Polycystic ovary syndrome (PCOS) is related to the presence of low-quality oocytes. This study aims to examine the impact of N-acetyl cysteine (NAC), melatonin, and their combination on the parameters of follicular fluid (FF) and the quality of oocytes and embryos in women with PCOS.
Methods: This is a prospective randomized placebo-controlled clinical trial that was conducted on 60 Iranian women diagnosed with PCOS who were candidates for intracytoplasmic sperm injection (ICSI). They were randomly allocated into four groups of 15: Melatonin (received 3 mg of melatonin daily at 22:00), NAC (received 1800 mg of NAC per day), NAC+ melatonin, and placebo. The treatment started on the fifth day of the menstrual cycle and continued until the day of oocyte retrieval, lasting 40 days. Hormonal status, sperm parameters, oocyte morphology, fertilization rate and embryo quality were assessed. The data were analyzed using one-way ANOVA, considering a significance level of P≤0.05.
Results: The number of immature oocytes (1.27±0.88, P=0.006) and abnormal oocytes (2.1±1.1, P=0.001) were significantly lower in the NAC compared to the placebo group (3.33±1.35 and 3.7±1.7, respectively). Only the NAC group showed a significantly higher number of high-quality (grade I) embryos compared to the placebo group (2.87±1.45 vs 1.53±0.83; P=0.02). Insulin and luteinizing hormone (LH) levels were significantly lower in the melatonin (7±2.4 and 1.5±0.5, respectively) and NAC (7.1±2.5 and 1.5±0.5, respectively) groups (P=0.01) compared to the placebo group (9.5±2.9 and 1.8±0.6, respectively).
Conclusion: Both melatonin and NAC can improve the quality of embryo and oocyte in women with PCOS, but their combination has no significant positive effect.
Methods: This is a prospective randomized placebo-controlled clinical trial that was conducted on 60 Iranian women diagnosed with PCOS who were candidates for intracytoplasmic sperm injection (ICSI). They were randomly allocated into four groups of 15: Melatonin (received 3 mg of melatonin daily at 22:00), NAC (received 1800 mg of NAC per day), NAC+ melatonin, and placebo. The treatment started on the fifth day of the menstrual cycle and continued until the day of oocyte retrieval, lasting 40 days. Hormonal status, sperm parameters, oocyte morphology, fertilization rate and embryo quality were assessed. The data were analyzed using one-way ANOVA, considering a significance level of P≤0.05.
Results: The number of immature oocytes (1.27±0.88, P=0.006) and abnormal oocytes (2.1±1.1, P=0.001) were significantly lower in the NAC compared to the placebo group (3.33±1.35 and 3.7±1.7, respectively). Only the NAC group showed a significantly higher number of high-quality (grade I) embryos compared to the placebo group (2.87±1.45 vs 1.53±0.83; P=0.02). Insulin and luteinizing hormone (LH) levels were significantly lower in the melatonin (7±2.4 and 1.5±0.5, respectively) and NAC (7.1±2.5 and 1.5±0.5, respectively) groups (P=0.01) compared to the placebo group (9.5±2.9 and 1.8±0.6, respectively).
Conclusion: Both melatonin and NAC can improve the quality of embryo and oocyte in women with PCOS, but their combination has no significant positive effect.
Type of Study: Original |
Subject:
Reproductive Biology
Received: 2018/07/3 | Accepted: 2024/09/11 | Published: 2023/08/30
Received: 2018/07/3 | Accepted: 2024/09/11 | Published: 2023/08/30
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
